Summer 2025 Launch of ELEMENTS™ CBD Product Line in United States
VANCOUVER, BC / ACCESS Newswire / May 13, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a leading innovator in the North American cannabis and wellness sectors, is pleased to provide an update to shareholders on the advancement of its U.S. commercialization strategy.
Following the execution of the Manufacturing and Distribution Agreement with NF Skin and its logistics division, RT Fulfillment, Xebra has made significant progress toward the U.S. launch of its ELEMENTS™ CBD product line, which is now on track to debut in the summer of 2025.
Over the past month, Xebra and NF Skin have successfully completed:
Finalization of Key Product Formulations and SKUs, including ELEMENTS™ branded tinctures, gummies, topicals, and wellness supplements.
Completion of E-Commerce Planning and Compliance Readiness Activities, including digital asset creation, product registration, labeling review, and FDA-compliant claims vetting.
Development of Branded Packaging and Marketing Assets, readying the ELEMENTS™ line for both e-commerce and retail launch.
Integration into RT Fulfillment's Logistics and E-Commerce Infrastructure, enabling direct-to-consumer fulfillment and nationwide distribution across the United States.
"Since formalizing our partnership with NF Skin, we have rapidly advanced toward commercialization, and we are excited to confirm that ELEMENTS™ products will be available to U.S. consumers this summer," said Rodrigo Gallardo, Interim CEO of Xebra Brands. "With NF Skin's proven capabilities in manufacturing and logistics, we are poised to enter the U.S. CBD wellness market with a premium, high-quality product offering that aligns with Xebra's commitment to innovation and excellence."
This milestone supports Xebra's broader strategy to diversify its portfolio and drive near-term revenue from the rapidly growing U.S. CBD market. The Company will continue to update shareholders as ELEMENTS™ products approach commercial availability.
About Xebra Brands Ltd.
Xebra Brands Ltd. is a leading cannabis and wellness company focused on the development and commercialization of cannabis-derived consumer products in North America and Mexico. Through its federally licensed operations in Mexico and strategic partnerships in the U.S., Xebra is dedicated to building trusted brands that meet the evolving needs of consumers.
About NF Skin
Founded in 2003, NF Skin is a premier private label manufacturer of CBD-infused skincare, supplements, and wellness products. NF Skin operates out of GMP-certified U.S. facilities, offering end-to-end services from custom formulation to packaging and branding. Its logistics division, RT Fulfillment, provides comprehensive fulfillment and distribution services to support seamless customer experiences nationwide. Learn more at www.nfskin.com/fulfillment
This news release contains certain "forward-looking information" and "forward-looking statements", as such terms are defined under applicable securities laws (collectively, "forward-looking statements"). Forward-looking statements can be identified by the use of words and phrases such as "plans", "expects" ,"is expected", "budget", "scheduled," "estimates", "forecasts", "intends", "anticipates" or "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements herein include, but are not limited to, statements with respect Strategy 2025 and the Company's growth strategy into the CBD market, the roadmap to accelerate growth in the North American CBD market, the Company's expected growth pillars of Cultivation, Manufacturing and Retail and the planned business activities under each such pillar, that the Company is actively seeking to amend current provisions under the Company's Mexican cultivation licences that limit cultivation scale, the aim to collaborate with major agricultural institutions in Mexico for large-scale, low-cost outdoor cannabis cultivation, expectations with respect to the Company's legal proceedings in Mexico, including the results and timing thereof, the expectation that Chapingo University will initiate pilot projects once confined site approval is granted, the anticipation for the importation process the two CBD products, which were manufactured in partnership with Restorative Botanicals, to be completed by April 2025 and the expectation for launch shortly thereafter, the Company's plans for e-commerce partnerships with Amazon Mexico and Mercado Libre is Mexico and the intention to leveraging expertise from a major U.S. e-commerce partner for market expansion and that the Company is seeking partnerships with CBD brands and that such partnerships may expedite the Company's path to self-sustainability.
These forward-looking statements are based on current expectations and are subject to known and unknown risks, uncertainties and other factors, many of which are beyond Xebra's ability to predict or control and could cause actual results to differ materially from those contained in the forward-looking statements. Specific reference is made to Xebra's most recent annual management discussion and analysis on file with certain Canadian provincial securities regulatory authorities for a discussion of some of the factors underlying forward-looking statements, which include, without limitation, the inability of Xebra to retain the authorizations granted by COFEPRIS, the inability to successfully complete financings on terms acceptable to Xebra or at all, the inability to generate sufficient revenues or to raise sufficient funds to carry out its business plan; changes in government legislation, taxation, controls, regulations and political or economic developments in various countries; risks associated with agriculture and cultivation activities generally, including inclement weather, access to supply of seeds, poor crop yields, and spoilage; compliance with import and export laws of various countries; significant fluctuations in cannabis prices and transportation costs; the risk of obtaining necessary licenses and permits; inability to identify, negotiate and complete potential acquisitions, dispositions or joint ventures for any reason; the ability to retain key employees; dependence on third parties for services and supplies; non-performance by contractual counter-parties; general economic conditions; the continued growth in global demand for cannabis products and the continued increase in jurisdictions legalizing cannabis; and the timely receipt of regulatory approvals for license applications on terms satisfactory to Xebra. In addition, there is no assurance Xebra will: be a low-cost producer or exporter; obtain a dominant market position in any jurisdiction; have products that will be unique. The foregoing list is not exhaustive and Xebra undertakes no obligation to update or revise any of the foregoing except as required by law. Many of these uncertainties and contingencies could affect Xebra's actual performance and cause its actual performance to differ materially from what has been expressed or implied in any forward-looking statements made by, or on behalf of, Xebra. Readers are cautioned that forward-looking statements are not guarantees of future performance and readers should not place undue reliance on such forward-looking statements. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those set out in such statements.
